Efficacy of strontium ranelate on bone mineral density in men with osteoporosis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Arzneimittel-Forschung

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 20533764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008cited by this paper
• Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

  2008cited by this paper
• Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

  2008cited by this paper
• Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.

  2008cited by this paper
• Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.

  2008cited by this paper
• Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.

  2007cited by this paper
• Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate

  2007cited by this paper
• Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate

  2007cited by this paper
• Osteoporosis in men.

  2007cited by this paper
• Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation

  2006cited by this paper
• Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors

  2006cited by this paper
• Strontium Ranelate Reduces the Risk of Vertebral Fractures in Patients With Osteopenia

  2006cited by this paper
• BMD and Risk of Hip and Nonvertebral Fractures in Older Men:A Prospective Study and Comparison With Older Women

  2006cited by this paper
• Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older

  2006cited by this paper
• Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study

  2005cited by this paper
• Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

  2005cited by this paper
• Predictive Value of BMD for Hip and Other Fractures

  2005cited by this paper
• Prediction of Fracture Risk in Postmenopausal White Women With Peripheral Bone Densitometry: Evidence From the National Osteoporosis Risk Assessment

  2002cited by this paper
• Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS)

  2002cited by this paper
• Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study.

  2001cited by this paper
• Alendronate for the treatment of osteoporosis in men.

  2000cited by this paper
• Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  2000cited by this paper

• Advances in strontium-releasing biomaterials for bone repair.

  2025cites this paper
• Effect of nutrient-based alloying elements on biodegradable magnesium alloys: Evolution, challenges, and strategies for orthopaedic applications

  2025cites this paper
• Pharmacological Therapies for Osteoporosis: A Bayesian Network Meta-Analysis

  2022cites this paper
• The Influence of Rapid Solidification on Corrosion Behavior of Mg60Zn20Yb15.7Ca2.6Sr1.7 Alloy for Medical Applications

  2021cites this paper
• Integrative Medicine in Rehabilitation

  2021cites this paper
• Multifunctional Scaffolds and Synergistic Strategies in Tissue Engineering and Regenerative Medicine

  2021cites this paper
• Male Osteoporosis: Gender Differences in Pathophysiology, Clinical Aspects, Diagnosis and Treatment

  2020cites this paper
• Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials

  2019cites this paper
• Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis

  2017cites this paper
• Diretrizes da Sociedade Brasileira de Reumatologia para diagnóstico e tratamento da osteoporose em homens

  2017cites this paper
• Guidelines of the Brazilian Society of Rheumatology for the diagnosis and treatment of osteoporosis in men.

  2017cites this paper
• Männliche Osteoporose

  2016cites this paper
• Management of chronic pain in osteoporosis: challenges and solutions

  2016cites this paper
• Obowiązujące wskazania do prewencji i leczenia osteoporozy pomenopauzalnej — choroby miliona złamań

  2016cites this paper
• Clinical practice guidelines for posmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014).

  2015cites this paper
• Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis

  2015cites this paper
• Intravenous Treatment With Ibandronate Normalizes Bone Matrix Mineralization and Reduces Cortical Porosity After Two Years in Male Osteoporosis: A Paired Biopsy Study

  2014cites this paper
• A review on osteoporosis in men

  2014cites this paper
• Treatment of primary osteoporosis in men

  2014cites this paper
• Idiopathic Osteoporosis in Men

  2013cites this paper
• Osteoporosis in men

  2013cites this paper
• Osteoporosis in men: recent progress

  2013cites this paper
• Pharmacophysiology of bone and spinal fusion.

  2013cites this paper
• Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.

  2013cites this paper
• Therapeutic options in male osteoporosis

  2013cites this paper
• The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.

  2013cites this paper
• A Review of the 2008 Singapore Ministry of Health Clinical Practice Guidelines on Osteoporosis and an Update

  2012cites this paper
• Therapeutic Options for Low Bone Mineral Density in HIV-Infected Subjects

  2012cites this paper
• Osteoporosis in Men: Insights for the Clinician

  2011cites this paper
• Management of osteoporosis in elderly men.

  2011cites this paper
• Geneesmiddelen ter preventie van osteoporosische fracturen

  2011cites this paper
• Influence d'un phosphate de calcium substitué en strontium sur la physiologie de l'ostéoblaste humain en culture et évaluation de son potentiel de réparation osseusse chez la souris

  2011cites this paper
• Strontium ranelate: an effective solution for diverse fracture risks

  2010cites this paper
• Treatment of osteoporosis in men.

  2004cites this paper